188 related articles for article (PubMed ID: 23812490)
1. CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis.
Charbonneau B; Wang AH; Maurer MJ; Asmann YW; Zent CS; Link BK; Ansell SM; Weiner GJ; Ozsan N; Feldman AL; Witzig TE; Cunningham JM; Dogan A; Habermann TM; Slager SL; Novak AJ; Cerhan JR
Cancer Immunol Immunother; 2013 Sep; 62(9):1475-84. PubMed ID: 23812490
[TBL] [Abstract][Full Text] [Related]
2. C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma.
Song H; Tong D; Cha Z; Bai J
Mol Biol Rep; 2012 Sep; 39(9):8629-35. PubMed ID: 22707196
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
[TBL] [Abstract][Full Text] [Related]
4. CXC Chemokine Receptor Type 5 Gene Polymorphisms in a Cohort of Egyptian Patients with Diffuse Large B-Cell Lymphoma.
Makhlouf MM; Radwan ER; Khorshed OM; Fathi LM; Elmasry MM
Pathobiology; 2021; 88(3):211-217. PubMed ID: 33378752
[TBL] [Abstract][Full Text] [Related]
5. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
6. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia.
Lee KM; Lan Q; Kricker A; Purdue MP; Grulich AE; Vajdic CM; Turner J; Whitby D; Kang D; Chanock S; Rothman N; Armstrong BK
Hum Genet; 2007 Dec; 122(5):525-33. PubMed ID: 17891500
[TBL] [Abstract][Full Text] [Related]
7. Reassessment of non-hodgkins's lymphoma with a "nodular" growth variant: a clinicopathologic study of follicular, mantle cell and marginal zone lymphomas prospectively diagnosed with multiparameter analyses.
Kadowaki I; Ichinohasama R; Sasaki O; Kimura J; Kameoka JI; Meguro K; Endo K; Tobinai K; Sasaki T; Sawai T; Ooya K
Leuk Lymphoma; 1998 Oct; 31(3-4):393-403. PubMed ID: 9869204
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma.
Wang SS; Davis S; Cerhan JR; Hartge P; Severson RK; Cozen W; Lan Q; Welch R; Chanock SJ; Rothman N
Carcinogenesis; 2006 Sep; 27(9):1828-34. PubMed ID: 16543247
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
[TBL] [Abstract][Full Text] [Related]
12. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma.
Bassig BA; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Hu W; Leaderer B; Yeager M; Menashe I; Boyle P; Xu J; Zou K; Zhu Y; Chanock S; Rothman N; Lan Q
Environ Mol Mutagen; 2012 Mar; 53(2):145-51. PubMed ID: 22170086
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
[TBL] [Abstract][Full Text] [Related]
18. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study.
Purdue MP; Lan Q; Kricker A; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
Carcinogenesis; 2007 Mar; 28(3):704-12. PubMed ID: 17056605
[TBL] [Abstract][Full Text] [Related]
20. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
